PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
5.79%
Net income growth under 50% of AVGO's 92.44%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
15.22%
D&A growth well above AVGO's 0.52%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
4.55%
Some yoy growth while AVGO is negative at -5.28%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-1.35%
Both cut yoy SBC, with AVGO at -3.44%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-58.60%
Both reduce yoy usage, with AVGO at -62.78%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-292.38%
Both yoy AR lines negative, with AVGO at -27.86%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-56.86%
Negative yoy inventory while AVGO is 152.34%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-23.53%
Both negative yoy AP, with AVGO at -86.99%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
2728.57%
Some yoy usage while AVGO is negative at -91.77%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
3050.00%
Well above AVGO's 15.79%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-10.67%
Negative yoy CFO while AVGO is 5.35%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-39.81%
Negative yoy CapEx while AVGO is 2.86%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-125.00%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-99.85%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-100.15%
Both yoy lines negative, with AVGO at -81.82%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-112.02%
Both yoy lines negative, with AVGO at -117.39%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
56.44%
Repurchase growth above 1.5x AVGO's 3.65%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.